Compounds > malondialdehyde
Page last updated: 2024-08-21

malondialdehyde and nitroaspirin

malondialdehyde has been researched along with nitroaspirin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brzozowski, T; Konturek, PC; Konturek, SJ; Pawlik, MW; Pawlik, WW; S Kwiecien, S; Sliwowski, Z1
Abdellatif, KR; Chattopadhyay, M; Kashfi, K; Keefer, LK; Nia, KV; Pruski, A; Velazquez, CA1
Abdelrahman, AM; Farghaly, E; Gomaa, W; Ibrahim, M; Kelleni, M1

Other Studies

3 other study(ies) available for malondialdehyde and nitroaspirin

ArticleYear
Nitric oxide (NO)-releasing aspirin and (NO) donors in protection of gastric mucosa against stress.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2008, Volume: 59 Suppl 2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastric Mucosa; Immersion; Lipid Peroxidation; Male; Malondialdehyde; Molsidomine; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Rats; Rats, Wistar; Reactive Oxygen Species; Regional Blood Flow; Restraint, Physical; S-Nitroso-N-Acetylpenicillamine; Stomach Ulcer; Stress, Psychological; Superoxide Dismutase

2008
Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (NONO-ASA) as safe anti-inflammatory, analgesic, antipyretic, antioxidant prodrugs.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Antipyretics; Aspirin; Dinoprostone; Disease Models, Animal; Edema; Fever; Gastric Mucosa; Hydrazines; Hyperalgesia; Lipid Peroxidation; Male; Malondialdehyde; Molecular Structure; Prodrugs; Rats; Rats, Wistar; Stomach Ulcer; Superoxide Dismutase; Tumor Necrosis Factor-alpha

2010
Nitro-aspirin is a potential therapy for non alcoholic fatty liver disease.
    European journal of pharmacology, 2011, Jun-01, Volume: 659, Issue:2-3

    Topics: Alanine Transaminase; Animals; Aspirin; Cyclooxygenase 2; Fatty Liver; Gene Expression Regulation, Enzymologic; Liver; Male; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase Type II; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Triglycerides

2011